Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis
- PMID: 2013383
Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis
Abstract
Whether serum autoantibodies to neutrophil cytoplasmic components, previously found in ulcerative colitis, are also associated with primary sclerosing cholangitis was determined. In an enzyme-linked immunosorbent assay for immunoglobulin G neutrophil antibodies, neutrophil binding by primary sclerosing cholangitis sera was significantly greater than that for primary biliary cirrhosis, chronic hepatitis B, and chronic non-A, non-B hepatitis. Similar differences were seen when sera from patients with primary sclerosing cholangitis without evidence for ulcerative colitis were compared with sera from liver disease controls. Perinuclear immunofluorescence staining of neutrophils was exhibited by the majority of ulcerative colitis, primary sclerosing cholangitis, and primary sclerosing cholangitis without ulcerative colitis sera. The combination of elevated immunoglobulin G neutrophil antibodies and a perinuclear pattern was 65% sensitive and 100% specific for primary sclerosing cholangitis compared with the liver disease control sera. It is concluded that neutrophil cytoplasmic antibodies in ulcerative colitis and primary sclerosing cholangitis may be markers of shared underlying immunopathogenic mechanisms. Identification of the target antigen(s) may facilitate understanding of the underlying immune response and development of an improved disease marker assay.
Similar articles
-
Neutrophil cytoplasmic autoantibodies after liver transplantation in patients with primary sclerosing cholangitis.J Hepatol. 1993 Aug;19(1):8-14. doi: 10.1016/s0168-8278(05)80170-9. J Hepatol. 1993. PMID: 8301047
-
Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis.Gastroenterology. 1994 Aug;107(2):532-6. doi: 10.1016/0016-5085(94)90181-3. Gastroenterology. 1994. PMID: 8039629
-
Prevalence of anti-neutrophil antibody in primary sclerosing cholangitis and ulcerative colitis using an alkaline phosphatase technique.Gut. 1992 Oct;33(10):1370-5. doi: 10.1136/gut.33.10.1370. Gut. 1992. PMID: 1446862 Free PMC article.
-
Neutrophil autoantibodies as disease markers for ulcerative colitis.Immunol Res. 1991;10(3-4):479-84. doi: 10.1007/BF02919745. Immunol Res. 1991. PMID: 1955775 Review. No abstract available.
-
Dysplasia and colorectal cancer in a patient with ulcerative colitis and primary sclerosing cholangitis: a case report and a short review of the literature.J Crohns Colitis. 2013 Mar;7(2):e61-5. doi: 10.1016/j.crohns.2012.04.005. Epub 2012 Apr 30. J Crohns Colitis. 2013. PMID: 22552273 Review.
Cited by
-
Churg-Strauss syndrome.Thorax. 2000 Oct;55(10):870-7. doi: 10.1136/thorax.55.10.870. Thorax. 2000. PMID: 10992542 Free PMC article. Review. No abstract available.
-
The clinical relevance of ANCA in vasculitis.Clin Exp Immunol. 1993 Sep;93 Suppl 1(Suppl 1):7-11. doi: 10.1111/j.1365-2249.1993.tb06215.x. Clin Exp Immunol. 1993. PMID: 8365024 Free PMC article. Review. No abstract available.
-
PR3-ANCA: a promising biomarker in primary sclerosing cholangitis (PSC).PLoS One. 2014 Nov 14;9(11):e112877. doi: 10.1371/journal.pone.0112877. eCollection 2014. PLoS One. 2014. PMID: 25397578 Free PMC article.
-
Distinct IFNG methylation in a subset of ulcerative colitis patients based on reactivity to microbial antigens.Inflamm Bowel Dis. 2011 Jan;17(1):171-8. doi: 10.1002/ibd.21352. Inflamm Bowel Dis. 2011. PMID: 20848535 Free PMC article.
-
Stem cell-based therapies in inflammatory bowel disease: promises and pitfalls.Therap Adv Gastroenterol. 2016 Jul;9(4):533-47. doi: 10.1177/1756283X16642190. Epub 2016 Apr 25. Therap Adv Gastroenterol. 2016. PMID: 27366222 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical